These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38621620

  • 1. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H, Tadros MM, El Ridi R.
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [Abstract] [Full Text] [Related]

  • 2. Increased hepatic interleukin-1, arachidonic acid, and reactive oxygen species mediate the protective potential of peptides shared by gut cysteine peptidases against Schistosoma mansoni infection in mice.
    Tallima H, El Ridi R.
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011164. PubMed ID: 36920999
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Schistosoma mansoni Reinfection in Mice.
    Alves CC, Araujo N, Bernardes WPOS, Mendes MM, Oliveira SC, Fonseca CT.
    Front Immunol; 2018 Mar; 9():2488. PubMed ID: 30450095
    [Abstract] [Full Text] [Related]

  • 6. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, de Melo AL, Caliari MV, Almeida GT, Venancio TM, Verjovski-Almeida S, Oliveira SC.
    PLoS Negl Trop Dis; 2008 Oct 01; 2(10):e308. PubMed ID: 18827884
    [Abstract] [Full Text] [Related]

  • 7. Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice.
    Morais SB, Figueiredo BC, Assis NRG, Homan J, Mambelli FS, Bicalho RM, Souza C, Martins VP, Pinheiro CS, Oliveira SC.
    Front Immunol; 2018 Oct 01; 9():1762. PubMed ID: 30105029
    [Abstract] [Full Text] [Related]

  • 8. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R, Tallima H.
    J Parasitol; 2013 Apr 01; 99(2):194-202. PubMed ID: 22985345
    [Abstract] [Full Text] [Related]

  • 9. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
    El Ridi R, Tallima H, Mahana N, Dalton JP.
    Microbes Infect; 2010 Sep 01; 12(10):700-9. PubMed ID: 20452455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
    El Ridi R, Tallima H, Selim S, Donnelly S, Cotton S, Gonzales Santana B, Dalton JP.
    PLoS One; 2014 Sep 01; 9(1):e85401. PubMed ID: 24465551
    [Abstract] [Full Text] [Related]

  • 13. Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H, Montash M, Veprek P, Velek J, Jezek J, El Ridi R.
    Vaccine; 2003 Jul 04; 21(23):3290-300. PubMed ID: 12804860
    [Abstract] [Full Text] [Related]

  • 14. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
    Attallah AM, Abdel Aziz MM, Abbas AT, Elbakry KA, El-Sharabasy MM.
    J Helminthol; 2004 Sep 04; 78(3):189-94. PubMed ID: 15469619
    [Abstract] [Full Text] [Related]

  • 15. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H, Dvořák J, Kareem S, Abou El Dahab M, Abdel Aziz N, Dalton JP, El Ridi R.
    PLoS Negl Trop Dis; 2017 Mar 04; 11(3):e0005443. PubMed ID: 28346516
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A, Dalton JP, Ndao M.
    Vaccine; 2015 Jan 03; 33(2):346-53. PubMed ID: 25448114
    [Abstract] [Full Text] [Related]

  • 18. Sm16, A Schistosoma mansoni Immunomodulatory Protein, Fails to Elicit a Protective Immune Response and Does Not Have an Essential Role in Parasite Survival in the Definitive Host.
    Bernardes WPOS, de Araújo JM, Carvalho GB, Alves CC, de Moura Coelho AT, Dutra ITS, Teixeira SSF, de Azambuja Ribeiro RIM, de Moraes Mourão M, da Silva-Pereira RA, Fonseca CT.
    J Immunol Res; 2019 Jan 03; 2019():6793596. PubMed ID: 31886307
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.